![Luis Luna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Luis Eduardo Luna is the founder of Trueamaringos, founded in 2020.
Dr. Luna is currently an Advisor at Noetic Psychedelic.
Education history includes a doctorate from the University of Stockholm, conferred in 1989; a graduate degree from the University of Oslo, conferred in 1980; and an undergraduate degree from Madrid University, conferred in 1972.
Actieve functies van Luis Luna
| Bedrijven | Functie | Begin |
|---|---|---|
Noetic Psychedelic
 Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements. | Consultant / Adviseur | - |
Trueamaringos | Oprichter | 01-03-2020 |
Opleiding van Luis Luna
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrid University
 Madrid University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noetic Psychedelic
Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements. | Finance |
Trueamaringos |
